Sweden Cancerome Analysis Network - Breast : Genomic Profiling of Breast Cancer
Recruiting · NCT02306096 · Observational (researchers observe without assigning treatment) · Lead sponsor: Lund University
View the official record on ClinicalTrials.gov →What this trial is about
This study evaluates the genomic profiles of breast cancer in a prospective and population-based manner. In the first phase, breast tumors are analyzed by whole transcriptome RNA-sequencing. Gene expression profiles, mutational profiles, and transcript isoform-level data will be analyzed in the context of patient information, clinicopathological variables, and outcome, with the purpose to develop new molecular diagnostic assays for breast cancer. Additional genome-scale RNA, DNA, and protein analyses will be performed in the future.
Who can take part
Age range
No age limits stated
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- suspicion or confirmed diagnosis of primary breast cancer
- signed informed consent
Exclusion criteria
- lack of signed informed consent
Where it is running
10 locations listed.
- Södra Älvsborg Hospital - Borås, Sweden
- Hallands Hospital Halmstad - Halmstad, Sweden
- Helsingborg Hospital - Helsingborg, Sweden
- Kirurgiska kliniken - Jönköping, Sweden
- Blekinge County Hospital - Karlskrona, Sweden
- Central Hospital Kristianstad - Kristianstad, Sweden
- Skåne University Hospital - Lund, Sweden
- Skåne University Hospital - Malmö, Sweden
- Uppsala University Hospital - Uppsala, Sweden
- Central Hospital Växjö - Vaxjo, Sweden